Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/3a8921c5-7f88-4f2a-ac42-4bc77a137261/

TRLV

Trulieve Cannabis Corp.
Chart
8.62 USD
Latest Week 2026-07-10
HealthcareDrug Manufacturers - Specialty & GenericSMALL
Snapshot 2026-07-12 · 0.6w · Fresh
0.88
OS Score
89.0%
Value
78.0%
Quality
37.0%
Momentum
6/9
F-Score
0.833
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
OS 0.880
↗
Trending Value
✗
◆
Quality × Value
QV 0.833
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
20.6%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 89%
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
89.0%ile
P/S
1.4×
P/B
1.4×
E/P
0.0924
FCF Yield
0.205
EBITDA/EV
0.206
SH Yield
-0.084
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
13.00000000
/100 — 1=cheapest
VC2 (Trending Value)
25.00000000
/100
VC3 (Buyback)
11.00000000
/100
FCF yield of 20.5% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
78.0%ile
ROE
-0.069
ROA
-0.029
Net Margin
-0.069
Op Margin
0.127
GPA
0.251
D/E
1.40
Current
5.26
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.004
Stability
0.772
lower=better
Accruals
-0.129
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
37.0%ile
Max DD 12M
-16.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.88
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
94.6%
Sector Quality %ile
82.6%
P/B z-score
-0.27
Sector Avg OS
63.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
RIGL Rigel Pharmaceuticals Inc 99.0% 89.0% 93.0% 94.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 90.0% 91.0% 99.0%
TBPH Theravance Biopharma Inc 99.0% 90.0% 99.0% 88.0%
FBIO Fortress Biotech Inc 99.0% 98.0% 85.0% 90.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 83.0% 95.0%
NUTX Nutex Health Inc 98.0% 89.0% 98.0% 86.0%
CGEN Compugen 98.0% 89.0% 96.0% 85.0%
INVA Innoviva Inc 98.0% 94.0% 94.0% 75.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (89th) and quality (78th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
73.6% avg (6 factors)
Quality
C
45.7% avg (8 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends5 snapshots
Factor Persistence5 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.880—5—
Value %ile0.890—5—
Quality %ile0.780—5—
Momentum %ile0.370—0—
F-Score6.000—0—
Confidence0.712—2—
Volatility——0—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Earnings Yield (E/P)
0.0924
Price / Sales
1.42
Price / Book
1.42
Price / Cash Flow
5.98
FCF Yield
20.5%
EBITDA / EV
20.6%
Sales Yield (1/P·S)
0.7273
Shareholder Yield
Div + net buyback / mktcap
-8.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-6.9%
Return on Assets
-2.9%
Net Margin
-6.9%
Operating Margin
12.7%
Gross Profit / Assets
Novy-Marx GPA
25.1%
Debt / Equity
1.40
Current Ratio
5.26
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.129
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-0.4%
Earnings Stability (CV)
Lower = more stable
0.772
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
-8.4%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
13
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
25
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
11
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity